Noevir Holdings Co (TSE:4928) EBIT : 円11,442 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Noevir Holdings Co EBIT?

Noevir Holdings Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was 円2,630 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was 円11,442 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Noevir Holdings Co's annualized ROC % for the quarter that ended in Mar. 2024 was 16.90%. Noevir Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 38.26%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Noevir Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.14%.

Noevir Holdings Co EBIT Historical Data

The historical data trend for Noevir Holdings Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noevir Holdings Co EBIT Chart

Noevir Holdings Co Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EBIT

Get a 7-Day Free Trial

11,997.00

8,064.00

8,561.00

10,118.00

11,027.00

Noevir Holdings Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															2,421.00	3,031.00	2,246.00	3,535.00	2,630.00

Competitive Comparison of Noevir Holdings Co's EBIT

For the Household & Personal Products subindustry, Noevir Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Noevir Holdings Co's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Noevir Holdings Co's EV-to-EBIT falls into.

Noevir Holdings Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円11,442 Mil.

Noevir Holdings Co (TSE:4928) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Noevir Holdings Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	10520 * ( 1 - 38.98% )	/	( (38213	+	37743)	/ 2 )
=	6419.304	/	37978
=	16.90 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	71745	-	8745	-	( 24787	-	max(0, 11505	-	45541	+	24787	))
=	38213

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	75104	-	10149	-	( 27212	-	max(0, 12827	-	48400	+	27212	))
=	37743

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Noevir Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	10520	/	( ( (20270 + max(7723, 0))	+	(20104 + max(6902, 0)) )	/	2 )
=	10520	/	( ( 27993	+	27006 )	/	2 )
=	10520	/	27499.5
=	38.26 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(10415	+	8110	+	617)	-	(8745	+	0	+	2674)
=	7723

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(10512	+	8560	+	571)	-	(10149	+	0	+	2592)
=	6902

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Noevir Holdings Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	11442	/	160152.660
	=	7.14 %

Noevir Holdings Co EBIT Related Terms

Thank you for viewing the detailed overview of Noevir Holdings Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Noevir Holdings Co (TSE:4928) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Noevir Holdings Co Ltd (TSE:4928) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

6-13-1 Minatojimanakamachi, Chuo-ku, Kobe, JPN, 650-8521

Website

http://www.noevirholdings.co.jp

Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses, cosmetics, and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces and sells a broad range of products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in a number of countries across the world, and focuses on developing Asian markets.

Noevir Holdings Co (TSE:4928) Headlines

No Headlines